Trial Profile
Prevenar Post-Licensure Safety Study in Russia: Frequency Of Fever Post Vaccination
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Otitis media; Pneumococcal infections; Pneumonia
- Focus Adverse reactions
- Sponsors Pfizer
- 06 Jun 2017 New trial record